The Combination of Corona Discharge Plasma and ε-Polylysine for the Inactivation of Serratia liquefaciens.


Journal

Journal of food protection
ISSN: 1944-9097
Titre abrégé: J Food Prot
Pays: United States
ID NLM: 7703944

Informations de publication

Date de publication:
07 2023
Historique:
received: 15 11 2022
revised: 06 03 2023
accepted: 13 03 2023
medline: 26 6 2023
pubmed: 10 6 2023
entrez: 9 6 2023
Statut: ppublish

Résumé

The purpose of the study was to investigate the mechanism of inactivation of Serratia liquefaciens by different treatments, namely corona discharge plasma (CDP), ε-polylysine (ε-PL), and corona discharge plasma combined with ε-polylysine (CDP plus ε-PL). The results showed that the combined treatment of CDP and ε-PL exhibited significant antibacterial effects. The total number of colonies of S. liquefaciens dropped by 0.49 log CFU/mL following 4 min of CDP treatment, 4MIC ε-PL treatment for 6 h alone decreased the amounts of colonies by 2.11 log CFU/mL, and 6 h of treatment with 4MIC ε-PL after the bacterium was treated with CDP could decrease the number of colonies by 6.77 log CFU/mL. Scanning electron microscopy images showed that the combined treatment of CDP and ε-PL caused the most serious damage to the cell morphology. Electrical conductivity, nucleic acid, and PI staining indicated that the combined treatment dramatically enhanced the permeability of the cell membrane. In addition, the combined treatment led to a significant decrease in SOD and POD enzyme activities in S. liquefaciens, which prevented energy metabolism. Finally, the determination of free and intracellular ε-PL concentrations confirmed that the treatment of CDP could cause the bacteria to bind more ε-PL and exert more significant bacterial inhibition. Therefore, CDP and ε-PL had a synergistic effect in the inhibition of S. liquefaciens.

Identifiants

pubmed: 37295216
pii: S0362-028X(23)06750-9
doi: 10.1016/j.jfp.2023.100078
pii:
doi:

Substances chimiques

Polylysine 25104-18-1
Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

100078

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Sijia Hu (S)

College of Food Science and Light Industry, Nanjing Tech University, Nanjing 211800, China.

Xinfu Li (X)

College of Food Science and Light Industry, Nanjing Tech University, Nanjing 211800, China.

Qiang Xiong (Q)

College of Food Science and Light Industry, Nanjing Tech University, Nanjing 211800, China. Electronic address: xiongqiang@njtech.edu.cn.

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Humans Arthroplasty, Replacement, Elbow Prosthesis-Related Infections Debridement Anti-Bacterial Agents
Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation
Humans China Cerebral Hemorrhage Patient Care Bundles Length of Stay

Classifications MeSH